Unilever PLC
10 September 2003
Release: Immediate
UNILEVER AGREES TO SELL ITS
US AND CANADA ORAL CARE BRANDS TO CHURCH & DWIGHT
Unilever today announced that it has signed a definitive agreement to sell its
oral care brands in the United States and Canada to Church & Dwight of
Princeton, NJ. The transaction is expected to be completed in the fourth quarter
of 2003, subject to regulatory approvals. Unilever will receive $104 million in
cash at closing, plus additional performance-based cash payments of between $5
million and $12 million.
The sale includes, for the US and Canada, the Mentadent brand of toothpaste and
toothbrushes, Pepsodent and Aim toothpaste, and exclusive licensing rights to
Close-Up toothpaste. Sales of the business for the first six months of 2003 were
$61 million.
This action is another milestone in Unilever's Path to Growth strategy, which
includes paring down the number of brands in its portfolio regionally and
globally, and focusing resources on the company's leading brands. As announced
in the US last week, Unilever also reached an agreement to sell its Brut line of
male personal care products in the Americas.
Unilever remains fully committed to its oral care business outside the US and
Canada, where in many markets its brands hold leading or strong positions.
-o0o-
SAFE HARBOUR STATEMENT: This announcement may contain forward-looking statements
(within the meaning of the U.S. Private Securities Litigation Reform Act 1995).
Any forward-looking statements are based on current expectations with respect to
important risk factors. It is important to note that the actual results could
materially differ from the results anticipated in any forward-looking statements
which may be contained in this announcement. Factors which might cause
forward-looking statements to differ materially from actual results include,
among other things, the overall economic, political, social and business
conditions, the demand for our goods and services, competition in the market,
fluctuations in interest rates and foreign currencies, the impact and other
uncertainties of future acquisitions and disposals and any changes in the tax
laws and other legislation and regulation, in the jurisdictions in which we
operate.
We do not undertake any obligation to update any forward-looking statements
contained in or incorporated in this announcement to reflect actual results,
changes in assumptions or in other factors which may affect any forward-looking
statements.
September 10 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.